Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Cefazaflur has a broad-spectrum of in vitro antibacterial activity equal to or greater than that of the commercially-available cephalosporins. In addition, cefazaflur has activity against isolates of Enterobacter, Citrobacter and indole-positive Proteus; however, this activity decreased markedly when the MIC determinations were carried out with a large inoculum size. A similar inoculum effect was observed with cefamandole, however, cefoxitin's activity was relatively unchanged at increased inoculum sizes. Human serum had a relatively small effect on the in vitro activity of cefazaflur. Cefazaflur, a new cephalosporin for parenteral administration is currently under clinical investigation. This cephalosporin has been reported to have potent and broad-spectrum in vitro and in vivo activity when compared with the commercially-available cephalosporins.1,6) Its spectrum of activity is somewhat broader than the available cephalosporins.1,2,5,11) It is highly stable to the activity of B-lactamases produced by staphylococci). Cefazaflur has been reported to have good activity against anaerobic bacteria but was less active than cefoxitin against Bacteroides fragilis10). Cefazaflur is bound to serum proteins to about the same extent as is cephalothin, however, serum levels and half-life and urinary recovery, after parenteral administration, are somewhat greater than that of cephalothin3,4,9). Intramuscular administration of cefazaflur is less painful than that produced by cephalothin3). These studies were in part presented at the 16th Interscience Conference on Antimicrobial Agents and Chemotherapy and deal with the effect of human serum and inoculum size on the activity of cefazaflur.2) Cefazaflur (SK&F59962) Materials and Methods
Cefazaflur has a broad-spectrum of in vitro antibacterial activity equal to or greater than that of the commercially-available cephalosporins. In addition, cefazaflur has activity against isolates of Enterobacter, Citrobacter and indole-positive Proteus; however, this activity decreased markedly when the MIC determinations were carried out with a large inoculum size. A similar inoculum effect was observed with cefamandole, however, cefoxitin's activity was relatively unchanged at increased inoculum sizes. Human serum had a relatively small effect on the in vitro activity of cefazaflur. Cefazaflur, a new cephalosporin for parenteral administration is currently under clinical investigation. This cephalosporin has been reported to have potent and broad-spectrum in vitro and in vivo activity when compared with the commercially-available cephalosporins.1,6) Its spectrum of activity is somewhat broader than the available cephalosporins.1,2,5,11) It is highly stable to the activity of B-lactamases produced by staphylococci). Cefazaflur has been reported to have good activity against anaerobic bacteria but was less active than cefoxitin against Bacteroides fragilis10). Cefazaflur is bound to serum proteins to about the same extent as is cephalothin, however, serum levels and half-life and urinary recovery, after parenteral administration, are somewhat greater than that of cephalothin3,4,9). Intramuscular administration of cefazaflur is less painful than that produced by cephalothin3). These studies were in part presented at the 16th Interscience Conference on Antimicrobial Agents and Chemotherapy and deal with the effect of human serum and inoculum size on the activity of cefazaflur.2) Cefazaflur (SK&F59962) Materials and Methods
A quantitative semi-automated turbidimetric bioassay for cefazaflur, using Streptococcus faecium as the indicator, is described. Assays were run at pH 6.5 -7 for 3.75 hours at 37°C using 2-12,ug cefazaflur per ml assay broth for standards.The dose response line was plotted point to point using the natural log of the absorbance vs natural log of the concentration. This assay is both accurate and precise and is more rapid than traditional plate assays for antibiotics.Cefazaflur, SK&F 59962, is a cephalosporin with a broad spectrum of in vitro and in vivo antibacterial activity. The pharmacokinetics have been studied in several species of laboratory animals and in man1,2). Plate assays for antibiotics, while acceptable, may not provide adequate sample throughout during development of a new compound. The AutoturbR, a semiautomated system for doing photometric assays, has been shown capable of producing large numbers of precise assays of vitamins or antibiotics including several l-lactams3,4). This system is best suited for the assay of bulk or formulated samples rather than samples of body fluids from clinical specimens. This paper details our experience with the Autoturb® for assay of cefazaflur. Included in the study are (1) dose-response relationship, (2) effect of pH, (3) effect of incubation time, (4) assay precision as a function of pH, (5) standard response line plotting parameters and (6) a comparison with two chemical assays. Materials and MethodsSodium cefazaflur samples were prepared fresh daily in 1 % phosphate buffer, pH 6.0. The standard substance was kept in a dessicator at -20°C until used. The indicator culture used was Streptococcus faecium ATCC 10541. Culture conditions, media, and operation of the Autoturb® were described previously.') Separate standard response lines were prepared from data obtained from each of the four sampling loops of the Autoturb(D. Results from test samples from each loop were calculated using the standard response line prepared from that loop. Data were analyzed point to point using a plot of the natural log of the absorbance versus the natural log of the concentration.Chemical Assays: The cefazaflur content of samples was determined chemically using the automated hydroxylamine assay described for cefazolin') and by high pressure liquid chromotography (HPLC) described as follows: The HPLC assay was run at ambient temperature on a Chromatronix 3100 chromatograph using a strong anion-exchange resin column (DuPont 820960005) one meter long and 2.1 mm ID. The column was operated at 1,500 PSI and a flow rate of 1.3 ml/min. An ultraviolet detector operating at 254 nm was used. The mobile phase was 1.42% anhydrous sodium sulfate in distilled water adjusted to pH 3.5 with acetic acid. Samples were introduced to the column using a 20 Id loop. Under these conditions, the retention time for cefazaflur was about 11 minutes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.